The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock

Post time 2024-5-8 23:04:37

journal：Expert Review of Clinical Pharmacology

Authors：Timothy E. Albertson; James A. Chenoweth; Justin C. Lewis; Janelle V. Pugashetti; Christian E. Sandrock; Brian M. Morrissey

Published date：2022-8-3

DOI：10.1080/17512433.2022.2110067

PDF link：https://www.tandfonline.com/doi/pdf/10.1080/17512433.2022.2110067

Article link：http://dx.doi.org/10.1080/17512433.2022.2110067

Article Source：Informa UK Limited。

Remark：

Post time 2024-5-8 23:04:38

: This post has been completed
Completed attachments will be deleted within 24 hours.

Post time 2024-5-9 22:13:48

: This post has been completed
Completed attachments will be deleted within 24 hours.

[Taylor&Francis] The pharmacotherapeutic options in patients with catecholamine-resistant vasodilatory shock

Best Answer

Same Category

Latest Reply

Announcement

Enthusiastic users today